Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,778 public trials 699 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

CD19 /22 CAR T Cells (AUTO3) for the Treatment of B Cell Acute Lymphoblastic Leukemia (ALL)

NCT03289455

Conditions: B Acute Lymphoblastic Leukemia, B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +22 more
Locations: Great Ormond Street Hospital for Children NHS Foundation Trust London, United Kingdom

University College London Hospitals NHS Foundation Trust London, United Kingdom

Royal Manchester Children's Hospital Manchester, United Kingdom

View Trial Details

Completed

DLBCL Treatment in Children and Adolescents

NCT04726995

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

A Dose-finding Study of the Bromodomain (Brd) Inhibitor OTX015/ Birabresib (MK-8628) in Hematologic Malignancies (MK-8628-001)

NCT01713582

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +25 more
Locations: Not specified

View Trial Details

Completed

Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL)

NCT02593045

Conditions: Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Stanford Cancer Center Stanford, California, United States

Ohio State University Columbus, Ohio, United States

Hôpital Saint-Louis Paris, France

Leiden University Medical Center Leiden, Netherlands

View Trial Details

Completed

Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL

NCT02910063

Conditions: B-cell Non Hodgkin Lymphoma, Disease Attributes, Hematologic Diseases, +14 more
Locations: Research Site Duarte, California, United States

Research Site Baltimore, Maryland, United States

Research Site Oklahoma City, Oklahoma, United States

Research Site Greenville, South Carolina, United States

View all 31 locations

View Trial Details

Completed

Study of WP1220 for the Treatment of Adult Subjects With Cutaneous T-Cell Lymphoma (CTCL)

NCT04702503

Conditions: Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Medical University of Gdansk Gdansk, Poland

View Trial Details

Completed

Effect of RIC on BP and Inflammatory Response in Women With Pre-eclampsia

NCT03323762

Conditions: Cardiovascular Diseases, Female Urogenital Diseases and Pregnancy Complications, Gestational Hypertension, +17 more
Locations: Aarhus University hospital Aarhus, Denmark

Herning Hospital Herning, Denmark

Randers Hospital Randers, Denmark

View Trial Details

Completed

A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)

NCT01578499

Conditions: Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Los Angeles, California, United States

Palo Alto, California, United States

Chicago, Illinois, United States

Boston, Massachusetts, United States

View all 41 locations

View Trial Details

Completed

Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma

NCT00506129

Conditions: Disorder Related to Bone Marrow Transplantation, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole

NCT04564040

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +20 more
Locations: Research Site Berlin, Germany

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions